Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421489 | SCV000514924 | benign | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000619052 | SCV000736989 | likely benign | Cardiovascular phenotype | 2016-04-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001175627 | SCV001339298 | likely benign | Cardiomyopathy | 2019-07-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001448267 | SCV001651352 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2023-12-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001175627 | SCV002042862 | likely benign | Cardiomyopathy | 2020-06-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449046 | SCV004183046 | benign | Dilated cardiomyopathy 1D | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449047 | SCV004183058 | benign | Cardiomyopathy, familial restrictive, 3 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449045 | SCV004183069 | benign | Hypertrophic cardiomyopathy 2 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003884522 | SCV004699124 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TNNT2: BP4, BP7 |
All of Us Research Program, |
RCV001175627 | SCV004823971 | likely benign | Cardiomyopathy | 2024-01-03 | criteria provided, single submitter | clinical testing |